A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl) -3, 5, 7-triaza-1-azoniatricyclo [3.3.1.13,7]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo
- Vita M. Golubovskaya
- , Sheila Figel
- , Baotran T. Ho
- , Christopher P. Johnson
- , Michael Yemma
- , Grace Huang
- , Min Zheng
- , Carl Nyberg
- , Andrew Magis
- , David A. Ostrov
- , Irwin H. Gelman
- , William G. Cance
Research output: Contribution to journal › Article › peer-review
84
Scopus
citations